Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Angiogenesis and VEGF in Cancer
Esophageal Cancer Research and Treatment
Publication details
- Journal / source
- Phytomedicine
- Volume
- 154
- Pages
- 158036–158036
- Publication date
- 4 March 2026
- Language
- EN